HBAN
HEQ
JHI
JHS
HPS

Kenneth J. Phelan

Known title: DirectorCIK: 0001779467

Kenneth J. Phelan's purchase track record

How the stock did after each of Kenneth J. Phelan's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
14
of 14 since November 3, 2021
Stock higher 6 months later
64%
3 months: 71%
Median 6-month return
+2.7%
3 months: +2.3%
Beat the S&P 500
36%
median -3.9% vs. index
PurchaseStockAmount3 months6 months
1/27/2026JHI$10K-1.2%-0.6%
1/27/2026HEQ$10K+6.1%+9.3%
1/26/2026HPF$10K+0.4%+2.1%
1/26/2026BTO$10K+2.6%+14.1%
1/26/2026JHS$10K-3.9%-5.2%
1/26/2026HTD$10K+6.1%+11.7%
1/26/2026HPS$10K+1.9%+1.8%
1/26/2026HPI$10K+1.5%+3.3%
1/26/2026PDT$10K+3.4%+4.2%
11/5/2025CVSA$50K+3.0%+18.3%
4/26/2023HBAN$216K+14.0%-10.0%
2/10/2022CVSA$100K+35.2%+65.7%
2/7/2022HBAN$120K-16.0%-13.0%
11/3/2021HBAN$314K-1.5%-12.5%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

HBAN Earnings Outlook and Valuation Concerns Highlighted. Analysts expect Huntington Bancshares' third‑quarter earnings to decline, prompting a view that the stock may trade below its fair value. A recent valuation note suggests the shares are about 21 % undervalued based on current earnings multiples. The company also appears on lists of high‑yield dividend stocks, with a 5.7 % yield, which may attract income‑focused investors. These factors keep the stock in focus as the earnings release approaches.

this person other insiders at HBAN

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 28, 2026

JHI Announces Annual Meeting; Peer Fund Discount Widens. John Hancock Investors Trust announced dates for its annual shareholder meeting. Separately, a report noted that a related fund, HFRO, is seeing its discount widen. JHI is currently trading near the bottom of its 52-week range, with technical indicators showing selling pressure.

this person other insiders at JHI

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 28, 2026

JHS Announces Annual Meeting; Featured in Fixed Income Article. John Hancock Income Securities Trust announced its annual shareholder meeting and record dates. Additionally, the fund was mentioned in a SeekingAlpha article discussing strategies that pair 5% bonds with 6% yield funds. The stock is currently trading near its 52-week low, with technical signals showing rejection at support levels.

this person other insiders at JHS
this person other insiders at HPF
this person other insiders at BTO
this person other insiders at PDT

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 10, 2026

Covista receives mixed analyst coverage and rating update. Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.

this person other insiders at CVSA

Transaction History

HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HEQ▲ Buy$10K
JHI▲ Buy$10K
JHS▲ Buy$9K
HBAN▲ Buy$0
HPS▲ Buy$10K
HPF▲ Buy$10K
HPI▲ Buy$10K
BTO▲ Buy$10K
HTD▲ Buy$10K
JHS▲ Buy$2K
PDT▲ Buy$10K
HBAN▼ Sell$0
HBAN▼ Sell$0
HBAN▲ Buy$0
HBAN▲ Buy$0
CVSA▼ Sell$38K
CVSA▲ Buy$140K
CVSA▲ Buy$50K
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
CVSA▲ Buy$140K
CVSA▼ Sell$58K
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$43K
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$0
HBAN▲ Buy$41K
HBAN▲ Buy$39K
CVSA▼ Sell$41K
CVSA▲ Buy$140K
HBAN▲ Buy$41K
HBAN▲ Buy$41K
HBAN▲ Buy$0
HBAN▲ Buy$216K
HBAN▲ Buy$39K
HBAN▲ Buy$39K
CVSA▼ Sell$40K
CVSA▲ Buy$125K
HBAN▲ Buy$39K
HBAN▲ Buy$39K
HBAN▲ Buy$0
HBAN▲ Buy$42K
CVSA▲ Buy$100K
HBAN▲ Buy$14K
HBAN▲ Buy$106K
CVSA▼ Sell$35K
CVSA▲ Buy$125K
HBAN▲ Buy$314K

We use analytics to understand how market-wall is used. No personal data is sold.